Novel suturelesss scleral IOL fixation technique successful

Article

A novel sutureless scleral IOL fixation technique is successful in patients with insufficient posterior capsule support.

A novel sutureless scleral IOL fixation technique is successful in patients with insufficient posterior capsule support, proves a study in the journal Eye.

Dr Y. Totan et al., Department of Ophthalmology, Fatih University, Medical School, Emek, Turkey, included eight eyes of seven patients in the study. Scleral tunnels were prepared by inserting a 25 G transconjunctival sutureless vitrectomy (TSV) microcannulas using the trocars.

Anterior vitrectomy was completed via the clear corneal paracentesis with an anterior chamber maintainer (ACM). Then the three-piece foldable IOL haptics were incarcerated into the scleral tunnels.

There were no complications recorded such as postoperative endophthalmitis, glaucoma, IOL tilt/decentralization and retinal detachment. There was less incidence of surgical-induced astigmatism because the foldable IOL was injected through a clear corneal incision.

Although the procedure could cause minimal trauma, it also provides good IOL stabilization, a decrease in IOL tilt, shorter operation time and postoperative quiet eye.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.